Nayyar GM., Breman JG, et al. Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa. Lancet Infect Dis. 2012 Jun; 12:6: 488-496.

Abstract Poor-quality antimalarial drugs lead to drug resistance and inadequate treatment, which pose an urgent threat to vulnerable populations and jeopardize progress and investments in combating malaria. Emergence of artemisinin resistance or tolerance in Plasmodium falciparum on the Thailand—Cambodia border makes protection of the effectiveness of the drug supply imperative. We reviewed published and unpublished…

[...]

2 Universities & A Modeling Society Have Been Pwned!

(Check out the Urban Dictionary’s definition of "pwned") Websites hacked by rogue online pharmacies this week: May 28, 2012 Every week we receive an email with the newest listings on Google for online pharmacies. In each email there are always a few hacked websites that are now unwitting advertisers for counterfeit drugs. Drug counterfeiters first crack…

[...]

Angola Customs Agents Find Vast Store of Fake Malaria Drugs in China Shipment

In June of 2012, Angola Customs agents conducting a routine search of cargo shipped from China, they found 1.4 million packets of counterfeit Coartem, a Malaria medication produced by Novartis. The resulting seizure of fake drugs would have, if genuine, been enough to treat over half of Angola’s annual Malaria patients. Who: Angola Customs Service.…

[...]

Counterfeit Adderall

Counterfeit Adderall Contains Wrong Active Ingredients, Warns FDA    Images of counterfeit Adderall courtesy of the FDA.

[...]

Counterfeit Version of Teva’s Adderall Purchased On Internet Contains Tramadol and Acetaminophen

This is a reprint of the FDA Alert.

The U.S. Food and Drug Administration is warning consumers and health care professionals about a counterfeit version of Teva Pharmaceutical Industries’ Adderall 30 milligram tablets that is being purchased on the Internet. Adderall, which is approved to treat attention deficit hyperactivity disorders (ADHD) and narcolepsy, is a prescription drug classified as a controlled substance – a class of drugs for which special controls are required for dispensing by pharmacists.

FDA’s preliminary laboratory tests revealed that the counterfeit version of Teva’s Adderall 30 mg tablets contained the wrong active ingredients. Adderall contains four active ingredients – dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. Instead of these active ingredients, the counterfeit product contained tramadol and acetaminophen, which are ingredients in medicines used to treat acute pain.

[...]

Partnership for Safe Medicines Praises G8 Action to Combat Drug Counterfeiting

Washington, D.C. (May 21, 2012) – Marv Shepherd, PhD, president of the Partnership for Safe Medicines, today released the following statement regarding news that global leaders at the G8 Summit have addressed the growing threat posed by counterfeit medicines: “The commitment to combat rogue online pharmacies made at this past weekend’s G8 Summit reinforces the…

[...]

Senate Letter Image

Read the full letter to Congress from more than 30 patient, healthcare and business groups.

[...]

Patient, Healthcare and Business Groups Oppose Breaking the Closed, Secure Drug Supply Chain

Leading Health Care, Business, Labor and Advocacy Groups Join
Together to Oppose Drug Importation as Part of the Prescription
Drug User Fee Act (PDUFA)

Importation Undermines Drug Safety Protocols, Could Lead to Influx of Dangerous Counterfeit Drugs

Washington, D.C. (May 21, 2012) – In a letter sent today to members of the U.S. Senate, the Partnership for Safe Medicines (PSM), a public health group comprised of more than 65 organizations committed to the safety of prescription drugs and protecting consumers against counterfeit, substandard or otherwise unsafe medicines, joined with leading patient, health care, business and advocacy groups in strongly opposing any amendments that would permit legal importation as part of the Prescription Drug User Fee Act (PDUFA). If allowed to move forward, importation would unnecessarily expose patients to increased risk of dangerous and potentially life-threatening counterfeit medicines making their way into the United States.

Among the organizations included in the letter: the American Pharmacists Association, the Kidney Cancer Association, the National Association of Manufacturers, the Pharmaceutical Industry Labor Management Association (PILMA) and the U.S. Chamber of Commerce.

“Despite the United States having the most secure drug supply chain in the world, recent incidents such as the discovery of fake Avastin prove we must remain ever vigilant,” said PSM Chairman Marvin D. Shepherd, PhD. “Contrary to claims made by importation advocates, there is no regulation for products trans-shipped through ‘safe’ countries such as Canada and the United Kingdom. Americans would be put at great risk and importation would erode the FDA’s ability to regulate prescription medicines, opening the door for more criminals to operate bogus online pharmacies that prey upon our citizens.”

[...]